Kiniksa Pharmaceuticals International, plc SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE144Kiniksa Pharmaceuticals International, plcKNSASep 4

   Michael R Megna, planned sale of KNSA shares

   Michael R Megna, reporting

2. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSASep 3

   6 insider filings

   Mark Ragosa, insider filing for KNSA

   Show all 6

   • 4Insider filing for KNSASep 3
   • 4Insider filing for KNSASep 3
   • 4Insider filing for KNSASep 3
   • 4Insider filing for KNSASep 3
   • 4Insider filing for KNSASep 3
   • 4Insider filing for KNSASep 3

   Mark Ragosa, reporting

3. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAAug 21

   Barry D Quart, insider filing for KNSA

   Barry D Quart, reporting

4. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAAug 4

   Richard S Levy, insider filing for KNSA

   Richard S Levy, reporting

5. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAJul 31

   G Bradley Cole, insider filing for KNSA

   G Bradley Cole, reporting

6. ROUTINE144Kiniksa Pharmaceuticals International, plcKNSAJul 29

   2 Form 144 notices

   Eben Tessari, planned sale of KNSA shares

   Show all 2

   • 144Planned insider sale of KNSA sharesJul 29
   • 144Planned insider sale of KNSA sharesJul 29

   Eben Tessari, reporting

7. ROUTINESCHEDULE 13GKiniksa Pharmaceuticals International, plcKNSAJul 29

   Ownership stake disclosure by BlackRock, Inc.

   BlackRock, Inc., filed by

8. NOTABLE10-QKiniksa Pharmaceuticals International, plcKNSAJul 28

   Quarterly report

9. ROUTINE8-KKiniksa Pharmaceuticals International, plcKNSAJul 28

   Current report

10. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAJul 6

    2 insider filings

    Dhiraj H Malkani, insider filing for KNSA

    Show all 2

    • 4Insider filing for KNSAJul 6
    • 3New insider at KNSAJul 6

    Dhiraj H Malkani, reporting

11. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAJun 2

    8 insider filings

    Kimberly J Popovits, insider filing for KNSA

    Show all 8

    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2
    • 4Insider filing for KNSAJun 2

    Kimberly J Popovits, reporting

12. ROUTINE8-KKiniksa Pharmaceuticals International, plcKNSAMay 29

    Current report

13. NOTABLESCHEDULE 13D/AKiniksa Pharmaceuticals International, plcKNSAMay 26

    Ownership stake disclosure by BAKER BROS. ADVISORS LP (amended)

    BAKER BROS. ADVISORS LP, filed by

14. ROUTINE8-KKiniksa Pharmaceuticals International, plcKNSAMay 26

    Current report

15. ROUTINESCHEDULE 13G/AKiniksa Pharmaceuticals International, plcKNSAMay 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

16. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAMay 5

    John F. Paolini, insider filing for KNSA

    John F. Paolini, reporting

17. ROUTINE144Kiniksa Pharmaceuticals International, plcKNSAMay 1

    John F. Paolini, planned sale of KNSA shares

    John F. Paolini, reporting

18. ROUTINE8-KKiniksa Pharmaceuticals International, plcKNSAMay 1

    Current report

19. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAMay 1

    Sanj K Patel, insider filing for KNSA

    Sanj K Patel, reporting

20. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAApr 30

    Sanj K Patel, insider filing for KNSA

    Sanj K Patel, reporting

21. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAApr 29

    Barry D Quart, insider filing for KNSA

    Barry D Quart, reporting

22. ROUTINE144Kiniksa Pharmaceuticals International, plcKNSAApr 28

    Sanj K Patel, planned sale of KNSA shares

    Sanj K Patel, reporting

23. NOTABLE10-QKiniksa Pharmaceuticals International, plcKNSAApr 28

    Quarterly report

24. ROUTINE8-KKiniksa Pharmaceuticals International, plcKNSAApr 28

    Current report

25. ROUTINEARSKiniksa Pharmaceuticals International, plcKNSAApr 16

    Annual report to shareholders

26. ROUTINEDEFA14AKiniksa Pharmaceuticals International, plcKNSAApr 16

    Additional proxy materials

27. ROUTINEDEF 14AKiniksa Pharmaceuticals International, plcKNSAApr 16

    Proxy statement

28. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAApr 13

    2 insider filings

    Michael R Megna, insider filing for KNSA

    Show all 2

    • 4Insider filing for KNSAApr 13
    • 4Insider filing for KNSAApr 13

    Michael R Megna, reporting

29. ROUTINE144Kiniksa Pharmaceuticals International, plcKNSAApr 9

    2 Form 144 notices

    Ross Moat, planned sale of KNSA shares

    Show all 2

    • 144Planned insider sale of KNSA sharesApr 9
    • 144Planned insider sale of KNSA sharesApr 9

    Ross Moat, reporting

30. ROUTINE4Kiniksa Pharmaceuticals International, plcKNSAApr 8

    5 insider filings

    Eben Tessari, insider filing for KNSA

    Show all 5

    • 4Insider filing for KNSAApr 8
    • 4Insider filing for KNSAApr 8
    • 4Insider filing for KNSAApr 8
    • 4Insider filing for KNSAApr 8
    • 4Insider filing for KNSAApr 8

    Eben Tessari, reporting

Older filings on EDGAR